ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Studies of Patients With Skin Disease, Patients With Neurological Degenerations, and Normal Volunteers

This study has been completed.

Sponsored by: National Cancer Institute (NCI)
Information provided by: National Institutes of Health Clinical Center (CC)
ClinicalTrials.gov Identifier: NCT00001164
  Purpose

It is proposed that patients with skin disease due to presumed immunologic, genetic or viral-induced abnormalities, patients with neurological degenerations, and normal controls be evaluated with various in vitro studies of immunologic, genetic, and virologic function. This is to include studies of peripheral blood (cells and serum) as well as studies of skin obtained with a biopsy instrument. In addition, studies of gastrointestinal function will be performed where appropriate.


Condition
Healthy
Muscular Dystrophy
Retinal Degeneration
Skin Diseases
Virus Diseases

Genetics Home Reference related topics:   X-linked juvenile retinoschisis   

MedlinePlus related topics:   Muscular Dystrophy    Skin Conditions   

U.S. FDA Resources

Study Type:   Observational
Official Title:   Studies of Patients With Skin Disease, Patients With Neurological Degenerations, and Normal Volunteers

Further study details as provided by National Institutes of Health Clinical Center (CC):

Study Start Date:   July 1978
Estimated Study Completion Date:   June 2000

Detailed Description:

It is proposed that patients with skin disease due to presumed immunologic, genetic or viral-induced abnormalities, patients with neurological degenerations, and normal controls be evaluated with various in vitro studies of immunologic, genetic, and virologic function. This is to include studies of peripheral blood (cells and serum) as well as studies of skin obtained with a biopsy instrument. In addition, studies of gastrointestinal function will be performed where appropriate.

  Eligibility
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes

Criteria

Patients with skin diseases of presumed genetic, immunologic, or virologic origin are eligible.

Patients with neurological degenerations are eligible, including patients with inflammatory, neoplastic and viral skin diseases and also heterozygous carriers of such inherited diseases.

Volunteers without skin diseases are eligible, except children.

  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00001164

Locations
United States, Maryland
National Cancer Institute (NCI)    
      Bethesda, Maryland, United States, 20892

Sponsors and Collaborators
  More Information


Publications:

Study ID Numbers:   780099, 78-C-0099
First Received:   November 3, 1999
Last Updated:   March 4, 2008
ClinicalTrials.gov Identifier:   NCT00001164
Health Authority:   United States: Federal Government

Keywords provided by National Institutes of Health Clinical Center (CC):
Genetic Evaluation  
Immunologic Evaluations  
Inflammatory Skin Disease  
Muscular Dystrophies  
Neoplastic Skin Diseases
Neuronal Degenerations
Retinal Degenerations
Viral Diseases

Study placed in the following topic categories:
Skin Diseases
Eye Diseases
Retinal Degeneration
Healthy
Virus Diseases
Muscular Dystrophies
Muscular Diseases
Muscular Disorders, Atrophic
Musculoskeletal Diseases
Neuromuscular Diseases
Genetic Diseases, Inborn
Atrophy
Muscular dystrophy
Retinal Diseases
Retinal degeneration

Additional relevant MeSH terms:
Nervous System Diseases

ClinicalTrials.gov processed this record on December 03, 2008




Links to all studies - primarily for crawlers